Tackling AMR, SBRI Healthcare’s Competition 25, November 2024
Microbira is excited to announce that we have progressed to the second stage of SBRI Healthcare’s Competition 25: Accelerating Innovations to Tackle Antimicrobial Resistance (AMR)! This prestigious competition seeks groundbreaking technologies to address critical challenges in AMR, a significant threat to public health identified as a priority in the NHS Long Term Plan
SBRI Healthcare’s Competition 25 focuses on four key areas:
- Point of care diagnostics, monitoring, and susceptibility testing
- Prescribing decision support and risk stratification
- Novel care delivery methods
- Infection prevention and control (IPC)
Our project aims to enhance diagnostic processes by leveraging existing NHS pathways, thereby improving accessibility and equity in healthcare. By focusing on point-of-care diagnostics and decision support, we strive to provide clinicians with rapid, accurate tools to combat AMR effectively.
Advancing to the second stage signifies a significant milestone for Microbira. It reflects our commitment to innovation and our dedication to addressing the global challenge of antimicrobial resistance. We are optimistic about the opportunity to further this project and make a lasting impact on diagnostics within healthcare systems.
Fingers crossed as we await the results—we’re optimistic about the opportunity to further this project and make a lasting impact on diagnostics in healthcare systems. Stay tuned on our news page for updates!
